Tuesday - June 30, 2026

Category Archives: Science

BCL-2 Inhibitors Market is Projected to Reach USD 16 Billion by 2036, Driven by Expanding Hematologic Oncology Applications and Next-Generation Apoptosis-Targeting Therapies | DelveInsight

The BCL-2 Inhibitors Market is witnessing substantial growth driven by increasing incidence of hematologic malignancies, growing adoption of targeted therapies, rising awareness of apoptosis-based cancer treatment strategies, and a robust pipeline of next-generation BCL-2 inhibitors. The anticipated launch of emerging … Continue reading →

Vaccines Market to Reach $67.91 Billion by 2030, Driven by Expanding Immunization Programs and Advancements in Vaccine Technologies

Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030 According to MarketsandMarkets™, The global vaccines market (excluding COVID-19) is … Continue reading →

The Substrate Theory of Everything Proposes a Groundbreaking Solution to the Cosmological Constant Problem and Unifies Gravity with Quantum Mechanics

“For nearly a century, physicists have been searching for a way to reconcile gravity with quantum mechanics. The Substrate Theory offers a principled approach that derives both from the same foundational framework, and in doing so, it provides a natural … Continue reading →

Diffuse Large B-Cell Lymphoma Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

The Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Market Size in the 7MM is going to be ~USD 1,843 million in 2025, and expected to grow with a CAGR of 7.6% during the forecast perio

DelveInsight’s “Chronic Inflammatory Demyelinating Polyneuropathy Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Chronic Inflammatory Demyelinating Polyneuropathy market trends in the United States, EU4 (Germany, France, Italy, … Continue reading →

Hemophilia A Pipeline Gains Momentum: 40+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Hemophilia A Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in the Hemophilia A pipeline landscape. It covers the Hemophilia A pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

The Diabetic Neuropathy Therapeutics Market Size (7MM) is projected to grow with a significant CAGR over the forecast period of 2026-2036

DelveInsight’s “Diabetic Neuropathy Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Diabetic Neuropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the … Continue reading →

Claudin 18.2 Directed Therapies Market is Projected to Reach USD 16 Billion by 2036, Driven by Expanding Precision Oncology Applications and Robust Pipeline Advancements | DelveInsight

The Claudin 18.2 Directed Therapies Market is poised for significant growth, driven by the increasing adoption of biomarker-driven oncology treatments, rising prevalence of gastric and pancreatic cancers, expanding use of companion diagnostics, and advancements in antibody-based therapeutics. The expected launch … Continue reading →